Annual Total Long Term Liabilities
$6.61 M
+$500.00 K+8.18%
December 31, 2023
Summary
- As of February 7, 2025, EVOK annual total long term liabilities is $6.61 million, with the most recent change of +$500.00 thousand (+8.18%) on December 31, 2023.
- During the last 3 years, EVOK annual total long term liabilities has risen by +$1.50 million (+29.32%).
- EVOK annual total long term liabilities is now -65.57% below its all-time high of $19.20 million, reached on December 31, 2012.
Performance
EVOK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, EVOK quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, EVOK quarterly long term liabilities has stayed the same.
- EVOK quarterly long term liabilities is now -100.00% below its all-time high of $19.20 million, reached on December 31, 2012.
Performance
EVOK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EVOK Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | 0.0% |
| 3 y3 years | +29.3% | -100.0% |
| 5 y5 years | +100.0% | -100.0% |
EVOK Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +17.8% | -100.0% | at low |
| 5 y | 5-year | at high | -100.0% | -100.0% | at low |
| alltime | all time | -65.6% | -100.0% | -100.0% | at low |
Evoke Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $6.61 M(+8.2%) | $0.00(-100.0%) |
| Sep 2023 | - | $6.49 M(+2.0%) |
| Jun 2023 | - | $6.36 M(+2.0%) |
| Mar 2023 | - | $6.24 M(+2.0%) |
| Dec 2022 | $6.11 M(+8.9%) | $6.11 M(+1.9%) |
| Sep 2022 | - | $6.00 M(+2.4%) |
| Jun 2022 | - | $5.86 M(+2.2%) |
| Mar 2022 | - | $5.74 M(+2.2%) |
| Dec 2021 | $5.61 M(+9.8%) | $5.61 M(+2.3%) |
| Sep 2021 | - | $5.49 M(+2.4%) |
| Jun 2021 | - | $5.36 M(+2.4%) |
| Mar 2021 | - | $5.24 M(+2.4%) |
| Dec 2020 | $5.11 M(>+9900.0%) | $5.11 M(+149.1%) |
| Sep 2020 | - | $2.05 M(+2.6%) |
| Jun 2020 | - | $2.00 M(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $3.70 M(-9.6%) | $3.70 M(-38.8%) |
| Sep 2017 | - | $6.05 M(+34.3%) |
| Jun 2017 | - | $4.51 M(-21.9%) |
| Mar 2017 | - | $5.77 M(+40.9%) |
| Dec 2016 | $4.09 M(-3.3%) | $4.09 M(-19.7%) |
| Sep 2016 | - | $5.10 M(>+9900.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $3.68 M(-13.0%) |
| Dec 2015 | $4.23 M(+0.9%) | $4.23 M(-3.1%) |
| Sep 2015 | - | $4.37 M(+40.8%) |
| Jun 2015 | - | $3.10 M(-15.9%) |
| Mar 2015 | - | $3.69 M(-12.1%) |
| Dec 2014 | $4.20 M(+176.4%) | $4.20 M(>+9900.0%) |
| Sep 2014 | - | $14.70 K(-13.0%) |
| Jun 2014 | - | $16.90 K(-98.6%) |
| Mar 2014 | - | $1.17 M(-22.8%) |
| Dec 2013 | $1.52 M(-92.1%) | $1.52 M(-19.2%) |
| Sep 2013 | - | $1.88 M(>+9900.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $1.70 M(-91.2%) |
| Dec 2012 | $19.20 M(>+9900.0%) | $19.20 M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Evoke Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Evoke Pharma?
- What is Evoke Pharma annual total long term liabilities year-on-year change?
- What is Evoke Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Evoke Pharma?
- What is Evoke Pharma quarterly long term liabilities year-on-year change?
What is Evoke Pharma annual total long term liabilities?
The current annual total long term liabilities of EVOK is $6.61 M
What is the all time high annual total long term liabilities for Evoke Pharma?
Evoke Pharma all-time high annual total long term liabilities is $19.20 M
What is Evoke Pharma annual total long term liabilities year-on-year change?
Over the past year, EVOK annual total long term liabilities has changed by +$500.00 K (+8.18%)
What is Evoke Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of EVOK is $0.00
What is the all time high quarterly long term liabilities for Evoke Pharma?
Evoke Pharma all-time high quarterly total long term liabilities is $19.20 M
What is Evoke Pharma quarterly long term liabilities year-on-year change?
Over the past year, EVOK quarterly total long term liabilities has changed by $0.00 (0.00%)